This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van den Wijngaard, A. Articles by Olijve, W. Search for Related Content PubMed PubMed Citation Articles by van den Wijngaard, A. Articles by Olijve, W.

Antiestrogens Specifically Up-Regulate Bone Morphogenetic Protein-4 Promoter Activity in Human Osteoblastic Cells

Department of Applied Biology (A.v.d.W., C.J.C.B., W.O.) Department of Cell Biology (E.J.J.v.Z.) University of Nijmegen 6525 ED Nijmegen, The Netherlands
N.V. Organon (W.R.M., R.D., C.J.C.B., S.M., W.O.) Target Discovery Unit 5340 BH Oss, The Netherlands

Bone morphogenetic protein-4 (BMP-4) plays an important role in the onset of endochondral bone formation in humans, and a reduction in BMP-4 expression has been associated with a variety of bone diseases. Here we describe, by transient transfection assays in bone cells, that the human BMP-4 promoter recently characterized in our laboratory can be stimulated specifically by antiestrogens but not by estrogens or other steroid hormones. This activity is dependent on the presence of the estrogen receptor (ER)-, although the promoter lacks a consensus estrogen-responsive element. No activity was observed in the presence of ERß, but synergy was observed when both ER subtypes were cotransfected. The observed stimulation of BMP-4 promoter activity by antiestrogens appeared bone cell specific and was reversed upon addition of estrogens. Since antiestrogens are known to be effective in hormone replacement therapies for postmenopausal women, this observation may help to develop new strategies for treatment and prevention of osteoporosis.

This article has been cited by other articles:

				J. L. Kipp, S. M. Kilen, T. K. Woodruff, and K. E. Mayo Activin Regulates Estrogen Receptor Gene Expression in the Mouse Ovary J. Biol. Chem., December 14, 2007; 282(50): 36755 - 36765. [Abstract] [Full Text] [PDF]

				N. L. Cho, S. H. Javid, A. M. Carothers, M. Redston, and M. M. Bertagnolli Estrogen Receptors {alpha} and {beta} Are Inhibitory Modifiers of Apc-Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice Cancer Res., March 1, 2007; 67(5): 2366 - 2372. [Abstract] [Full Text] [PDF]

				M. J. Perry, S. Gujra, T. Whitworth, and J. H. Tobias Tamoxifen Stimulates Cancellous Bone Formation in Long Bones of Female Mice Endocrinology, March 1, 2005; 146(3): 1060 - 1065. [Abstract] [Full Text] [PDF]

				J. Frasor, J. M. Danes, B. Komm, K. C. N. Chang, C. R. Lyttle, and B. S. Katzenellenbogen Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype Endocrinology, October 1, 2003; 144(10): 4562 - 4574. [Abstract] [Full Text] [PDF]

				V. Viereck, C. Grundker, S. Blaschke, B. Niederkleine, H. Siggelkow, K.-H. Frosch, D. Raddatz, G. Emons, and L. C. Hofbauer Raloxifene Concurrently Stimulates Osteoprotegerin and Inhibits Interleukin-6 Production by Human Trabecular Osteoblasts J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4206 - 4213. [Abstract] [Full Text] [PDF]

				S. Zhou, G. Turgeman, S. E. Harris, D. C. Leitman, B. S. Komm, P. V. N. Bodine, and D. Gazit Estrogens Activate Bone Morphogenetic Protein-2 Gene Transcription in Mouse Mesenchymal Stem Cells Mol. Endocrinol., January 1, 2003; 17(1): 56 - 66. [Abstract] [Full Text] [PDF]

				T. Yamamoto, F. Saatcioglu, and T. Matsuda Cross-Talk between Bone Morphogenic Proteins and Estrogen Receptor Signaling Endocrinology, July 1, 2002; 143(7): 2635 - 2642. [Abstract] [Full Text] [PDF]

				R. V. Weatherman, C.-Y. Chang, N. J. Clegg, D. C. Carroll, R. N. Day, J. D. Baxter, D. P. McDonnell, T. S. Scanlan, and F. Schaufele Ligand-Selective Interactions of ER Detected in Living Cells by Fluorescence Resonance Energy Transfer Mol. Endocrinol., March 1, 2002; 16(3): 487 - 496. [Abstract] [Full Text] [PDF]

				C. R. Dhore, J. P.M. Cleutjens, E. Lutgens, K. B.J.M. Cleutjens, P. P.M. Geusens, P. J.E.H.M. Kitslaar, J. H.M. Tordoir, H. M.H. Spronk, C. Vermeer, and M. J.A.P. Daemen Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1998 - 2003. [Abstract] [Full Text] [PDF]

				F. Schaufele, C.-y. Chang, W. Liu, J. D. Baxter, S. K. Nordeen, Y. Wan, R. N. Day, and D. P. McDonnell Temporally Distinct and Ligand-Specific Recruitment of Nuclear Receptor-Interacting Peptides and Cofactors to Subnuclear Domains Containing the Estrogen Receptor Mol. Endocrinol., December 1, 2000; 14(12): 2024 - 2039. [Abstract] [Full Text]